Net income increased 69.5%
Net income changed +69.5% from the comparable as-filed period.
$749,408→$1.3M3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →CCEL financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Gross debt decreased 1.7%
Gross debt changed -1.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$8.4M→$8.2M4 prior comparisons
Reported total debt decreased 1.7%
Reported total debt changed -1.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$8.4M→$8.2M4 prior comparisons
Current liabilities decreased 16.9%
Current liabilities changed -16.9% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$18.5M→$15.3M4 prior comparisons
Operating income increased 15.4%
Operating income changed +15.4% from the comparable as-filed period.
$1.9M→$2.2M3 prior comparisons
Operating cash flow / net income decreased 73.5%
Operating cash flow / net income changed -73.5% from the comparable as-filed period.
3.38→0.90 prior comparisons
Inventory decreased 18.6%
Inventory changed -18.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$655,254→$533,5574 prior comparisons
Research & development decreased 13.0%
Research & development changed -13.0% from the comparable as-filed period.
$61,625→$53,6243 prior comparisons
Current assets increased 12.8%
Current assets changed +12.8% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$11.7M→$13.2M4 prior comparisons
Cost of revenue decreased 10.4%
Cost of revenue changed -10.4% from the comparable as-filed period.
$1.8M→$1.6M3 prior comparisons
Shares outstanding increased 0.1%
Shares outstanding changed +0.1% from the comparable as-filed period. The change ranks at the 29th percentile of 7 prior comparable changes.
8,055,150→8,062,6507 prior comparisons
Debt / assets moved 5 bp lower
Debt / assets changed -5 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
13.28%→13.23%4 prior comparisons
Total assets decreased 1.4%
Total assets changed -1.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$63.2M→$62.3M4 prior comparisons
Selling, general & administrative decreased 2.5%
Selling, general & administrative changed -2.5% from the comparable as-filed period.
$3.9M→$3.8M3 prior comparisons
Trade receivables increased 0.0%
Trade receivables changed +0.0% from the comparable as-filed period.
$6.8M→$6.8M2 prior comparisons
Total assets decreased 5.8%
Total assets changed -5.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$64.4M→$60.7M4 prior comparisons
Net income increased 55.9%
Net income changed +55.9% from the comparable as-filed period.
$355,785→$554,5863 prior comparisons
Net debt decreased 6.2%
Net debt changed -6.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$8.3M→$7.8M4 prior comparisons
Operating income decreased 19.8%
Operating income changed -19.8% from the comparable as-filed period.
$1.5M→$1.2M3 prior comparisons
Gross debt decreased 1.7%
Gross debt changed -1.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$8.4M→$8.3M4 prior comparisons
Reported total debt decreased 1.7%
Reported total debt changed -1.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$8.4M→$8.3M4 prior comparisons
Research & development decreased 24.2%
Research & development changed -24.2% from the comparable as-filed period.
$131,711→$99,7813 prior comparisons
Operating cash flow / net income increased 67.5%
Operating cash flow / net income changed +67.5% from the comparable as-filed period.
1.99→3.330 prior comparisons
Capital expenditure decreased 47.6%
Capital expenditure changed -47.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$62,408→$32,7014 prior comparisons
Shares outstanding increased 0.1%
Shares outstanding changed +0.1% from the comparable as-filed period. The change ranks at the 14th percentile of 7 prior comparable changes. This reverses 6 consecutive comparable moves in the opposite direction.
8,057,150→8,062,6507 prior comparisons
Current ratio increased 18.3%
Current ratio changed +18.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
0.6→0.714 prior comparisons
Current assets decreased 13.4%
Current assets changed -13.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$13.1M→$11.3M4 prior comparisons
Cost of revenue decreased 9.7%
Cost of revenue changed -9.7% from the comparable as-filed period.
$1.9M→$1.7M3 prior comparisons
Debt / assets moved 57 bp higher
Debt / assets changed +57 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
13.06%→13.63%4 prior comparisons
Selling, general & administrative increased 8.5%
Selling, general & administrative changed +8.5% from the comparable as-filed period.
$4.3M→$4.6M3 prior comparisons
Trade receivables decreased 0.3%
Trade receivables changed -0.3% from the comparable as-filed period.
$6.9M→$6.9M2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.